Well it appears that the beneficiary of the share issue is...

Well it appears that the beneficiary of the share issue is someone or something other than a CURRENT director or their indirect holdings.

My guess is it is Fintan Walton, now at a lot more than arms length and a candidate for consultancy fees relating to success in the Lyramid divestment program if it exists.

We await confirmation or at least an update to accompany the 4C.

The Covid epidemic will have taken a toll in the research world in other countries with massive lockdowns keeping people at home including researchers. This will slow everything up with the hands on work and I suspect all the analysis will suffer as a result.

The only way they can take a lab home is on a leash.